Expression of members of the cadherin-/catenin-protein family in juvenile angiofibromas;Expression von proteinen der cadherin- und catenin-proteinfamilie bei juvenilen angiofibromen

Laryngo- Rhino- Otologie

Volumn 82, Issue 5, 2003, Pages 353-357

  Rippel, C ^a   Plinkert, P K ^a   Schick, Bernhard ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Catenin; Aetiology; Angiofibroma

Indexed keywords

ALPHA CATENIN; ANDROGEN RECEPTOR; BETA CATENIN; CADHERIN; CATENIN; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; UVOMORULIN;

ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CYTOPLASM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NASOPHARYNX FIBROMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR SENSITIVITY; STROMA CELL; TUMOR GROWTH;

ADOLESCENT; ANGIOFIBROMA; BETA CATENIN; CADHERINS; CONNECTIVE TISSUE; CYTOSKELETAL PROTEINS; DESMOPLAKINS; ENDOTHELIUM, VASCULAR; GAMMA CATENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICROSCOPY, FLUORESCENCE; PARANASAL SINUS NEOPLASMS; SPHENOID SINUS; TRANS-ACTIVATORS;

EID: 0038200953     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39731     Document Type: Article

References (24)

1. Schick B, Kahle G. Radiological findings in angiofibroma. Acta Radiol Radiological 2000; 41: 585-593
2. Beham A, Beham-Schmid C, Regauer S, Auböck L, Stammberger H. Nasopharyngeal angiofibroma. True neoplasm or vascular malformation. Adv Anat Path 2000; 7: 36-46
3. Schick B, Plinkert PK, Prescher A. Die vaskuläre Komponente: Gedanken zur Entstehung des Angiofibroms. Laryngo Rhino Otol 2002; 81: 280-284
4. Ferouz AS, Mohr RM, Paul P. Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: an association? Otolaryngol Head Neck Surg 1995; 113: 435-439
5. Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology 1993; 105: 1550-1552
6. Guertl B, Beham A, Zechner R, Stammberger H, Hoefler G. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol 2000; 31: 1411-1413
7. Brabletz T, Jung A, Kirchner T. β-Catenin and the morphogenesis of colorectal cancer. Virchows Arch 2002; 441: 1-11
8. Barth AL, Nathke IS, Welson WJ. Cadherins, Catenins, and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 1997; 9: 683-690
9. Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z. Linking β-Catenin to androgen-signaling pathway. J Biol Chem 2002; 277: 11336-11344
10. Henderson BR, Galea M, Schuechner S, Leung L. Lymphoid enhancer factor-1 blocks APC-mediated nuclear export and degradation of β-catenin: regulation by histone deacetylase 1. J Biol Chem 2002; 277: 24258-24264
11. Pawlowski JE, Retel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME. Liganded androgen receptor interaction with β-catenin. J Biol Chem 2002; 277: 20702-20710
12. Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent β-Catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 2001; 158: 1073-1078
13. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002; 34: 255-268
14. Aoki M, Hecht A, Kruse U, Kemler R, Vogt PK. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor-1. PNAS 1999; 96: 139-144
15. Koh SS, Li H, Lee YH, Widelitz RB, Chuong CM, Stallcup MR. Synergistic coactivator function by CARM1 and β-catenin with two different classes of DNA-binding transcriptional activators. J Biol Chem 2002; 277: 26031-26035
16. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, van Cutsem E, Bapat B, van Roy F, Cassiman JJ, Alman BA. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999; 18: 6615-6620
17. Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunhistochemical study of 24 cases. Mod Pathol 1998; 11: 1122-1126
18. Gates GA, Rice DH, Koopmann CF, Schuller DE. Flutamide-induced regression of angiofibroma. Laryngoscope 1992; 102: 641-644
19. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev 2000; 14: 1319-1331
20. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147: 631-644
21. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-405
22. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-Cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996; 135: 1643-1654
23. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. Transforming growth factor β-1mediates epithelial to mesenchymal transdifferentiation through RhoA-dependent mechanism. Mol Biol Cell 2001; 12: 27-36
24. Dillard DG, Cohen C, Muller S, Del Gaudio J, Reichman O, Parrish B, Rackley D, Gal AA. Immunolocalization of activated transforming growth factor β1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 2000; 126: 723-725